VEGFA and eye disorder: The development of anti-vascular endothelial growth factor (anti-VEGF) therapies has advanced treatment for neovascular eye diseases, but these drugs have drawbacks and there is a lack of pharmacotherapies for other ocular diseases (Figure 1A) despite consistent and intense expansion in market potential for ocular therapeutics (Kompella et al., 2010).